Literature DB >> 3181370

Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds.

L Cicurel1, B P Schmid.   

Abstract

Whole rat embryos cultured during the early stages of organogenesis were subjected to a panel of selected chemicals. Of seventeen known in vivo teratogens, seventeen also induced specific malformations in embryos grown in culture. Of ten chemicals which were reported to be negative in in vivo rat teratogenicity studies, eight also did not provoke dysmorphogenic effects in vitro. Of five additionally tested retinoids, all induced multiple malformations. However, concentrations used to induce these effects varied considerably, isotretinoin inducing malformations at 10(-5) M and arotinoid at 10(-11) M. The results indicate qualitatively as well as quantitatively a high predictability of this in vitro system and suggest that the postimplantation embryo culture system may also be useful in the prospective testing of new drugs and environmental chemicals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181370     DOI: 10.1007/bf01941180

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  18 in total

1.  Post-implantation embryo culture: validation with selected compounds for teratogenicity testing.

Authors:  L Cicurel; B P Schmid
Journal:  Xenobiotica       Date:  1988-06       Impact factor: 1.908

2.  Serum from monkeys with histories of fetal wastage causes abnormalities in cultured rat embryos.

Authors:  N W Klein; J D Plenefisch; S W Carey; W T Fredrickson; G P Sackett; T M Burbacher; R M Parker
Journal:  Science       Date:  1982-01-01       Impact factor: 47.728

3.  Xenobiotic influences on embryonic differentiation, growth and morphology in vitro.

Authors:  B P Schmid
Journal:  Xenobiotica       Date:  1985 Aug-Sep       Impact factor: 1.908

4.  Successful culture of rat embryos on human serum: use in the detection of teratogens.

Authors:  C L Chatot; N W Klein; J Piatek; L J Pierro
Journal:  Science       Date:  1980-03-28       Impact factor: 47.728

5.  Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture system.

Authors:  K T Kitchin; B P Schmid; M K Sanyal
Journal:  Biochem Pharmacol       Date:  1981-01-01       Impact factor: 5.858

6.  Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin A.

Authors:  B P Schmid
Journal:  Toxicology       Date:  1984-05-01       Impact factor: 4.221

7.  Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.

Authors:  J C Kraft; D M Kochhar; W J Scott; H Nau
Journal:  Toxicol Appl Pharmacol       Date:  1987-03-15       Impact factor: 4.219

8.  Teratogenicity induced in cultured rat embryos by the serum of procarbazine treated rats.

Authors:  B P Schmid; A Trippmacher; A Bianchi
Journal:  Toxicology       Date:  1982       Impact factor: 4.221

9.  Sodium salicylate teratogenicity in vitro.

Authors:  J C Greenaway; T H Shepard; A G Fantel; M R Juchau
Journal:  Teratology       Date:  1982-10

10.  In vitro teratogenicity of acetylsalicylic acid on rat embryos: studies with various culture conditions.

Authors:  L Cicurel; B Schmid
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-04
View more
  3 in total

1.  Robust regression in biological assay: application to the evaluation of alternative experimental techniques.

Authors:  A Marazzi; C Ruffieux; A Randriamiharisoa
Journal:  Experientia       Date:  1988-10-15

2.  Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture.

Authors:  R Bechter; G D Terlouw; M Tsuchiya; T Tsuchiya; A Kistler
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

3.  Comparative teratogenicity of nine retinoids in the rat.

Authors:  J A Turton; G B Willars; J N Haselden; S J Ward; C E Steele; R M Hicks
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.